Work

HIV seropositivity and viral non-suppression in transgender, non-binary, and gender-diverse people in primary care receiving gender-affirming hormone therapy in the USA between 2013 and 2019 (LEGACY): an observational, longitudinal, cohort study

Year: 2025

Type: article

Study design: Observational Study

Source: The Lancet HIV

DOI: 10.1016/s2352-3018(25)00004-9

Authors: Sari L Reisner, David R Pletta, Kenneth H Mayer, Madeline B Deutsch, Tonia Poteat, Jennifer Potter, Andrea L Wirtz, Alexander Harris, Juwan Campbell, Alex S Keuroghlian, Jaclyn M W Hughto, Alex Gonzalez, Asa E Radix

Institutions: Harvard University, University of Michigan, Fenway Health, Brown University, Beth Israel Deaconess Medical Center, University of California, San Francisco, Duke University, Johns Hopkins University, Massachusetts General Hospital, Columbia University

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: bronze

Funders: Patient-Centered Outcomes Research Institute, National Institutes of Health, National Institute on Minority Health and Health Disparities

Awards: Biopsychosocial Mechanisms Linking Gender Minority Stress to HIV Comorbidities, G4941400258

OpenAlex ID: W4408986940

FWCI: 6.542

Cites: 25

Cited by: 11

Related to: 10